APA

Nambi V., Morrison A. C., Hoogeveen R. C., Coresh J., Miles S., Rhodes C. E., Sharrett A. R., Boerwinkle B. E. & Ballantyne C. M. (20090819). Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study. : Texas Heart Institute journal.

Chicago

Nambi Vijay, Morrison Alanna C, Hoogeveen Ron C, Coresh Josef, Miles Shawn, Rhodes Charles Etta, Sharrett A Richey, Boerwinkle B Eric and Ballantyne Christie M. 20090819. Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study. : Texas Heart Institute journal.

Harvard

Nambi V., Morrison A. C., Hoogeveen R. C., Coresh J., Miles S., Rhodes C. E., Sharrett A. R., Boerwinkle B. E. and Ballantyne C. M. (20090819). Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study. : Texas Heart Institute journal.

MLA

Nambi Vijay, Morrison Alanna C, Hoogeveen Ron C, Coresh Josef, Miles Shawn, Rhodes Charles Etta, Sharrett A Richey, Boerwinkle B Eric and Ballantyne Christie M. Matrix metalloproteinase-1 and tissue inhibitors do not predict incident coronary artery disease in the atherosclerosis risk in communities (ARIC) study. : Texas Heart Institute journal. 20090819.